Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Other National MS Societies (Not listed here)
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Episode 32 with Dr. David Holtzman on the connection between MS and Alzheimer 's disease
Microglia in health and disease.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Sex hormones and multiple sclerosis: another informative failure.
8th World Congress on Controversies in Neurology (CONy)
Keystone Symposium: Mechanisms of Pro-Inflammatory Diseases - joint with - Innate Immunity and Determinants of Microbial Pathogenesis
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
European School of Neuroimmunology 15th Course
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Free MED IQ Live CME Event on Multiple Sclerosis Nov 22nd
endMS CONFERENCE
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.

Pages